GlassScriptPhysician profile
Natasha Rohani
NPI 1609237908
$1,752.21
in general payments reported to CMS, 2019-2025
14 companies · $219 in 2025
The $219 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $343 · 2022: $191 · 2023: $768 · 2024: $231 · 2025: $219.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,218.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,218.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $254.99 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $240.91 | 2022-2024 | Vaxneuvance, Gardasil 9, M-M-R II |
| Merz North America, INC. | $192.91 | 2021 | |
| Pfizer INC. | $176.29 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $152.72 | 2023-2024 | Fasenra, Flumist Quadrivalent |
| Galderma Laboratories, L.P. | $150.17 | 2021 | |
| Abbvie INC. | $125.48 | 2023 | |
| Kyowa Kirin, INC. | $120.06 | 2023 | |
| Sanofi Pasteur INC. | $104.56 | 2022-2025 | |
| Biogen, INC. | $96.51 | 2022 | |
| Glaxosmithkline, LLC. | $57.61 | 2022-2025 | Bexsero, Pediarix, Penmenvy |
| Cranial Technologies, INC | $38.43 | 2022-2023 | Doc Band |
| Novo Nordisk INC | $23.74 | 2023 | |
| Seqirus USA INC | $17.83 | 2024 | Flucelvax |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natasha Rohani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.